Molecular Characterization of Zoledronic acid Induced Growth Inhibition in Cancer
Zoledronic acid is a nitrogen-containing bisphosphonate widely used in the treatment of bone metastasis secondary to breast cancer. In addition, current clinical trials suggest direct antitumor effects, which may reduce the risk of overall disease progression in breast cancer patients. Consisten...
Tallennettuna:
Päätekijä: | |
---|---|
Muut tekijät: | |
Aineistotyyppi: | Dissertation |
Kieli: | englanti |
Julkaistu: |
Philipps-Universität Marburg
2010
|
Aiheet: | |
Linkit: | PDF-kokoteksti |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Internet
PDF-kokotekstiHyllypaikka: |
urn:nbn:de:hebis:04-z2010-06751 |
---|---|
Julkaisupäivä: |
2010-12-02 |
Datum der Annahme: |
2010-04-15 |
Downloads: |
20 (2024), 58 (2023), 104 (2022), 244 (2021), 157 (2020), 158 (2019), 151 (2018) |
Lizenz: |
https://rightsstatements.org/vocab/InC-NC/1.0/ |
Linkki aineistoon: |
https://archiv.ub.uni-marburg.de/diss/z2010/0675 https://doi.org/10.17192/z2010.0675 |